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Conditions are presented for separating the major tryptic peptides of E.coli tryptophanyl-transfer RNA syn- 
thetase by reversed-phase liquid chromatography using a water-methanol gradient in the presence of0.1% 
trifluoroacetic acid. Three of the peptides contain cysteine and are recovered in good yields if alkylated, 
but otherwise cannot be detected. A convenient post-digestion alkylation procedure is appropriate for use 
with small samples of protein which can be digested under educing conditions. These results will be of inter- 
est for studies of the labeling of sulfhydryl groups in other proteins. 
Reversed-phase HPLC Tryptic peptide mapping 
1. INTRODUCTION 
Tryptophanyl-tRNA synthetase from E. coli 
(EC 6.1 .1.2) is an example of an enzyme whose 
amino acid sequence was deduced from its gene se- 
quence [I]. Tryptic peptides representing about 
two-thirds of the molecule had previously been se- 
quenced by conventional peptide methods [2]. 
Three Cys-containing peptides were identified by 
peptide mapping [3], and the fourth Cys residue 
was found from the gene sequence [l] to occupy 
position 37, only 3 residues away from Cys-40. 
This report concerns a method for digesting, 
separating and identifying the major tryptic pep- 
tides from about 6 nmol Trp-tRNA synthetase. 
The effect of alkylation on the recovery of the Cys- 
containing peptides is discussed. 
2. MATERIALS AND METHODS 
Plasmid pCH6 and E. coli strain W3110 were 
generous gifts from Professor Charles Yanofsky. 
Strain W3 110 was transformed with pCH6 [4], and 
tryptophanyl-tRNA synthetase was purified from 
Trp-tRNA synthetase Cys-alkylation effect 
the transformed strain by the method of Joseph 
and Muench [5]. Peptide mapping was carried out 
on a 5-10 nmol scale. The pH and ionic strength 
of the enzyme solution were adjusted using a small 
column of Bio-gel P-2 (Biorad Laboratories) im- 
mediately prior to protease digestion. 300~1 of a 
solution containing typically about 0.8 mg/ml 
Trp-tRNA synthetase in 10 mM ,&mercapto- 
ethanol and 0.1 M potassium phosphate (pH 7.0), 
were chromatographed on a l-ml column of Bio- 
Gel P-2, equilibrated and eluted with 50 mM 
bicine (pH 8.0). The first 400~1 to elute from the 
column were discarded, and the enzyme was col- 
lected (95% recovery) in the next 3OOpl. The 
sample was then digested with trypsin for a total of 
4 h at 37°C. ~-PI aliquots (2 pg, 0.8% of weight of 
Trp-tRNA synthetase) of a stock solution of 
1 mg/ml trypsin (Worthington, 3 x crystallized) 
were added at 0, 1, and 2 h digestion time. Selected 
samples were treated post-digestion at 37°C with 
15 ~1 of 20 mM dithiothreitol (Calbiochem) for 
20 min, followed by 30 ~1 of 40 mM iodoacet- 
amide (Sigma, recrystallized) for 2 h. Samples 
were then frozen and stored at -20°C. 
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Table 1 
Expected tryptic peptides from E. coli Trp-tRNA synthetase 
Sequence 
numbering 
1. 
2. 
3. 
4. 
5. 
6. 
7. 
8. 
9. 
10. 
11. 
12. 
13. 
14. 
15. 
16. 
17. 
18. 
19. 
20. 
21. 
22. 
23. 
24. 
25. 
26. 
27. 
28. 
29. 
30. 
31. 
32. 
33. 
34. 
35. 
36. 
37. 
Met-Thr-Lys 
Pro-1le-Val-Phe-Ser-Gly-Ala-Gln-Pro-Ser-Gly-Glu-Leu-Thr-Ile-Gly-Asn-Tyr-Met-Gly-Ala- 
Leu-Arg 
Gln-Trp-Val-Lys 
Met-Gln-Asp-Asp-Tyr-His-Cys-Ile-Tyr-Cys-Ile-Val-Asp-Gln-His-Ala-Ile-Thr-Val-Arg 
Gln-Asp-Ala-Gln-Lys 
Leu-Arg-Lys 
Ala-Thr-Leu-Asp-Thr-Leu-Ala-Leu-Tyr-Leu-Ala-Cys-Gly-Ile-Asp-Pro-Glu-Lys 
Ser-Thr-Ile-Phe-Val-Gln-Ser-His-Val-Pro-Glu-His-Ala-Gln-Leu-Gly-Trp-Ala-Leu-Asn-Cys- 
Tyr-Thr-Tyr-Phe-Gly-Glu-Leu-Ser-Arg 
Met-Thr-Gln-Phe-Lys 
Asp-Lys 
Ser-Ala-Arg 
Tyr-Ala-Glu-Asn-Ile-Asn-Ala-Gly-Leu-Phe-Asp-Tyr-Pro-Val-Leu-Met-Ala-Ala-Asp-Ile-Leu- 
Leu-Tyr-Gln-Thr-Asn-Leu-Val-Pro-Val-Gly-Glu-Asp-Gln-Lys 
Gin-His-Leu-Glu-Leu-Ser-Arg 
Asp-Be-Ala-Gin-Arg 
Phe-Asn-Ala-Leu-Tyr-Gly-Glu-Jle-Phe-Lys 
Val-Pro-Glu-Pro-Phe-Ile-Pro-Lys 
Ser-Gly-Ala-Arg 
Val-Met-Ser-Leu-Leu-Glu-Pro-Thr-Lys-Lys 
Met-Ser-Lys 
Ser-Asp-Asp-Asn-Am 
Asn-Asn-Val-Ile-Gly-Leu-Leu-Glu-Asp-Pro-Lys 
Ser-Val-Val-Lys-Lys 
Ile-Lys-Arg 
Ala-Val-Thr-Asp-Ser-Asp-Glu-Pro-Pro-Val-Val-Arg 
Tyr-Asp-Val-Gln-Asn-Lys 
Ala-Gly-Val-Ser-Asn-Leu-Leu-Asp-Ile-Leu-Ser-Ala-Val-Thr-Gly-Gln-Ser-Ile-Pro-Glu-Leu- 
Glu-Lys 
Gln-Phe-Glu-Gly-Lys 
Met-Tyr-Gly-His-Leu-Lys 
Gly-Glu-Val-Ala-Asp-Ala-Val-Ser-Gly-Met-Leu-Thr-Glu-Leu-Gln-Glu-Arg 
Tyr-His-Arg 
Phe-Arg 
Asn-Asp-Glu-Ala-Phe-Leu-Gln-Gin-Val-Met-Lys 
Asp-Gty-Ala-Glu-Lys 
Ala-Ser-Ala-His-Ala-Ser-Arg 
Thr-Leu-Lys 
Ala-Val-Tyr-Gln-Ala-Ile-Glv-Phe-Val-Ala-Lys 
Arg 
314 
(l-3) 
(4-26) 
(27-30) 
(31-50) 
(51-55) 
(56-58) 
(59-76) 
(77- 106) 
(107-111) 
(112-113) 
(114-116) 
(117-151) 
(152-158) 
(159-163) 
(164-173) 
(174-181) 
(182-185) 
(186-195) 
(196-198) 
(199-203) 
(204-214) 
(215-219) 
(220-222) 
(223-234) 
(235-240) 
(241-263) 
(264-268) 
(269-274) 
(275-291) 
(292-294) 
(295-296) 
(297-307) 
(308-3 12) 
(313-319) 
(320-322) 
(323-333) 
(334) 
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For the separation of peptides, a digested sample 
was removed from the freezer, centrifuged 1 min 
in a microfuge (Eppendorf), and chromatographed 
at room temperature on a 4.6 x 250 mm Brownlee 
Aquapore RP-300 column. The peptides resulting 
from each 300-,J digestion were injected onto the 
column and eluted using a complex 225min gra- 
dient from 0.1% trifluoroacetic acid (Aldrich) in 
Hz0 to 0.07% trifluoroacetic acid in methanol 
(Baker, HPLC grade), pumped at 1 .O ml/min. The 
details of the gradient are illustrated in the figures. 
Individual peptide fractions were hydrolyzed 
20 h in constant boiling HCl, and analyzed on a 
microprocessor-controlled microbore amino acid 
analyzer designed at the University of Arkansas 
El. 
3. RESULTS AND DISCUSSION 
The expected tryptic peptides based on the gene 
sequence for E. coli Trp-tRNA synthetase [l] are 
shown in table 1. In these experiments, we em- 
phasized separation of the larger peptides and paid 
particular attention to the Cys-containing pep- 
tides, numbers 4, 7 and 8. Methanol rather than 
acetonitrile was chosen for the elution solvent 
because of the low cost and ease of handling 
methanol. We found that extending the time of a 
gradient significantly improved the resolution of 
peptides when using acidic methanol-water gra- 
dients at room temperature. 
Fig.1 shows a 4-h gradient elution profile for 
tryptic peptides of unalkylated E. coli Trp-tRNA 
synthetase. Peptides 4,7 and 8 (table 1) are notably 
absent from the profile. If the peptide mixture is 
alkylated after the proteolytic digestion but before 
the column chromatography, then peptides 4, 7 
and 8 appear in the second half of the gradient 
(fig.2). The result is most dramatic for peptide 4, 
which is recovered in high yield. Peptide 8 elutes in 
moderate yield just prior to peptide 26, while pep- 
tide 7 is split between two peaks due to incomplete 
digestion of the bond between peptides 6 and 7 
(lysine 58). 
The rationale for post-digestion alkylation has 
to do with the ease of handling small samples. It 
can be difficult to remove excess alkylating agent 
from nmol samples of protein without undue loss 
of the protein itself. We found that trypsin diges- 
tion proceeded favorably under reducing condi- 
tions (10 mM mercaptoethanol), that 4 mM 
iodoacetamide post-digestion was sufficient to 
alkylate peptide 4 in high yield, and that 4 mM 
iodoacetamide could be injected onto the Brownlee 
HPLC column without interfering with the peptide 
mapping. Such a procedure uses a relatively low 
level of iodoacetamide because the alkylation takes 
place at the peptide stage rather than at the intact 
protein stage. With this method, the problem of 
removing a large excess of alkylating agent prior to 
protease digestion is circumvented. 
Several factors could contribute to the apparent 
‘loss’ of Cys-containing peptides when an alkyl- 
ation step is omitted. It is possible that these 
TIME IN MINUTES 
Fig.1. Peptide map of unalkylated Trp-tRNA 
synthetase. Following trypsin digestion in the presence 
of mercaptoethanol, a 4 nmol sample was applied to a 
4.6 x 250 mm Brownlee Aquapore RP-300 column. The 
column was eluted at 1.0 ml/min with the indicated 
water-methanol gradient in the presence of 0.1% 
trifluoroacetic acid, room temperature. 
TIME IN MINUTES 
Fig.2. Peptide map of Trp-tRNA synthetase, alkylated 
post-digestion. A 6 nmol sample was treated exactly as 
in fig.1, except that it was exposed to 1 mM 
dithiothreitol followed by 4 mM iodoacetamide before 
the chromatographic separation of peptides. Newly 
appearing peaks include the Cys-containing peptides 4, 
7, 6-7, and 8, all of which elute between 165 and 
205 min. 
315 
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selected peptides react with the column or are 
strongly retained by the column. Perhaps more 
likely is the possibility that large polymers are 
formed through the random formation of disulfide 
bonds, particularly since peptide 4 contains two 
sulfhydryl groups. Polymers formed by such a 
mechanism would be retained on the column for 
long periods of time. 
These experiments may have important 
ramifications for sulfhydryl group labeling ex- 
periments in other enzyme systems, since those 
Cys-containing peptides that are not labeled are 
likely to be unobservable by reversed-phase 
HPLC. 
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